Lower CD4+ T-cell number expressing CD7+ characterizes HIV/hepatitis C virus coinfection compared with HIV and hepatitis C virus monoinfection [6]

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue 4, 2006, Pages 504-506

  Perrella, Alessandro ^a   Sbreglia, Costanza ^a   Atripaldi, Luigi ^a   Grattacaso, Stella ^a   Alone, Carla ^a   Esposito, Ciro ^a   Di Spirito, Antimo ^a   Perrella, Oreste ^a  

^a AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD7 ANTIGEN; INTERFERON;

ADULT; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOPATHOLOGY; LETTER; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TH1 CELL; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIGENS, CD7; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; MALE;

EID: 33750954942     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000243104.03265.e5     Document Type: Letter

References (11)

1. Greub G, Lederberger B, Battegay M, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet. 2000;356:1800-1805.
2. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology. 1999;30:1054-1058.
3. Anderson KB, Guest JL, Rimland D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clin Infect Dis. 2004;39:1507-1513.
4. Autran B, Legac E, Blanc C, et al. Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients. J Immunol. 1995;154:1408-1417.
5. Perrella A, Borgia G, Guida MG, et al. HIV and subtype 1b HCV: more similarities than differences in T helper subsets. J Gastroenterol Hepatol. 2005;20:1310-1312.
6. Perrella A, Perrella O, Sbreglia C, et al. Hepatic and peripheral T-lymphocyte patterns in patients with chronic hepatitis C infection: what correlation with histological activity? Int J Immunopathol Pharmacol. 2001;14:103-108.
7. Wallace DL, Matear PM, Davies DC, et al. CD7 expression distinguishes subsets of CD4(+) T cells with distinct functional properties and ability to support replication of HIV-1. Eur J Immunol. 2000;30:577-585.
8. Yao ZQ, Nguyen DT, Hiotellis AI, et al. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J Immunol. 2001;167:5264-5272.
9. Rosen HR, Miner C, Sasaki AW, et al. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology. 2002;35:190-198.
10. Eggena MP, Barugahare B, Jones N, et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol. 2005;174:4407-4414.
11. Cabrera R, Tu Z, Xu Y, et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology. 2004;40:1062-1071.